SK609, a novel dopamine D3 receptor agonist and norepinephrine transporter blocker with putative pro-cognitive actions, does not induce psychostimulant-like increases in risky choice during probabilistic discounting.

Psychopharmacology (Berl) · 2025 · PMC12084264 · PMID 39630237

Europe PMC DOI

hedged sentence

0.0693

closest p · 1.4× alpha

0.0693

boldest claim

The sentences

a strong trendp = 0.0693so close (0.05 < p ≤ 0.1)

4 b) revealed a significant main effect of feedback [F (1.000, 11.00) = 53.69, p < 0.0001] and a strong trend towards a significant main effect of treatment [F (1.000, 11.00) = 4.049, p = 0.0693], suggesting that this compound subtly increased both win-stay and lose shift behavior.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.